Cardiovascular disease, mortality, and magnesium in chronic kidney disease: growing interest in magnesium-related interventions
Abstract Magnesium (Mg) is an essential element that plays pivotal roles in a number of biological processes in the human body. Hypomagnesemia is involved in the pathophysiology of hypertension, vascular calcification, and metabolic derangements including diabetes mellitus and dyslipidemia, which ar...
Main Author: | Ryota Ikee |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-01-01
|
Series: | Renal Replacement Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41100-017-0142-7 |
Similar Items
-
Low plasma magnesium concentration and future abdominal aortic calcifications in moderate chronic kidney disease
by: Anique D. ter Braake, et al.
Published: (2021-02-01) -
Association of sclerostin with cardiovascular events and mortality in dialysis patients
by: Yun Zou, et al.
Published: (2020-01-01) -
Effect of magnesium on vascular calcification in chronic kidney disease patients: a systematic review and meta-analysis
by: Ya Zhan, et al.
Published: (2023-12-01) -
Lower serum magnesium is associated with vascular calcification in peritoneal dialysis patients: a cross sectional study
by: Amber O. Molnar, et al.
Published: (2017-04-01) -
The combined clinical impact of red blood cell distribution width and vascular calcification on cardiovascular events and mortality in patients with end-stage kidney disease
by: Da Won Kim, et al.
Published: (2022-05-01)